Targeted delivery of tumor antigens to activated dendritic cells via CD11c molecules induces potent antitumor immunity in mice. Jul 2009 - Clin. Cancer Res.; 15(14):1078-0432 [PMID:19584156] [Wei H] [Wang S] [Zhang D] [Hou S] [Qian W] [Li B] [Guo H] [Kou G] [He J] [Wang H] [Guo Y]
IFN-producing killer dendritic cells contribute to the inhibitory effect of poly I:C on the progression of murine melanoma. Jun 2008 - J. Immunother.; 31(6):1524-9557 [PMID:18528299] [Jiang Q] [Wei H] [Tian Z]
Cancer immunotherapy using in vitro genetically modified targeted dendritic cells. May 2008 - Cancer Res.; 68(10):1538-7445 [PMID:18483270] [Wei H] [Wang H] [Lu B] [Li B] [Hou S] [Qian W] [Fan K] [Dai J] [Zhao J] [Guo Y]
